PADULA, STEFANIA
 Distribuzione geografica
Continente #
AS - Asia 115
NA - Nord America 105
EU - Europa 96
SA - Sud America 9
AF - Africa 2
Totale 327
Nazione #
US - Stati Uniti d'America 101
SG - Singapore 58
RU - Federazione Russa 46
CN - Cina 28
VN - Vietnam 14
HK - Hong Kong 10
IT - Italia 9
SE - Svezia 9
BR - Brasile 8
DE - Germania 8
NL - Olanda 7
FI - Finlandia 5
FR - Francia 5
GB - Regno Unito 4
CA - Canada 2
CI - Costa d'Avorio 2
IE - Irlanda 2
IQ - Iraq 2
MX - Messico 2
AR - Argentina 1
BD - Bangladesh 1
IN - India 1
LB - Libano 1
PL - Polonia 1
Totale 327
Città #
Singapore 28
Moscow 12
Santa Clara 12
Ashburn 11
Chandler 10
Hong Kong 10
Beijing 7
Amsterdam 6
Los Angeles 6
Nanjing 6
Naples 6
Hanoi 5
Millbury 5
Munich 5
New York 4
Boardman 3
Ninh Bình 3
Princeton 3
Biên Hòa 2
Brooklyn 2
Ho Chi Minh City 2
London 2
Mexico 2
Napoli 2
Romainville 2
Atlanta 1
Baghdad 1
Boston 1
Brasília 1
Buffalo 1
Changsha 1
Da Nang 1
Denver 1
Elk Grove Village 1
Falkenstein 1
Falls Church 1
Frankfurt am Main 1
Hangzhou 1
Hefei 1
Helsinki 1
Hood River 1
Houston 1
Itu 1
Jacksonville 1
Jaguariúna 1
Kronberg 1
Macaé 1
New Delhi 1
Orem 1
Ottawa 1
Phủ Lý 1
Poplar 1
Porto Alegre 1
Quilmes 1
Raleigh 1
Regina 1
Rio de Janeiro 1
Santa Fe 1
Shijiazhuang 1
Tianjin 1
Três Rios 1
Turku 1
Várzea Paulista 1
Wilmington 1
Wroclaw 1
Zakho 1
Totale 197
Nome #
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 128
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 110
Right heart and pulmonary thromboembolism from extensive splanchnic vein thrombosis after splenectomy for myeloproliferative disease. 92
Totale 330
Categoria #
all - tutte 1.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 2 0 0 2 1 1 0
2021/202218 1 0 0 0 0 0 0 1 2 1 5 8
2022/202330 3 2 0 3 2 4 0 2 5 6 3 0
2023/202423 0 2 9 3 0 2 0 3 0 0 0 4
2024/2025106 3 14 0 2 2 6 12 3 6 8 41 9
2025/2026120 25 15 16 25 33 6 0 0 0 0 0 0
Totale 330